The department cited Moderna’s use of the messenger RNA technology, which it said “remains under-tested,” for the ...

Panel members had questions about whether a new FDA proposal to require randomized trials for vaccines in healthy adults ...

CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...

The Trump administration has canceled $766 million awarded to drugmaker Moderna Inc. to develop a vaccine against potential ...

The Trump administration has cancelled a contract awarded to Moderna for the late-stage development of its bird flu vaccine ...

The Trump administration has canceled a contract awarded to Moderna for the late-stage development of its bird flu vaccine ...

US cancels over $700 million in Moderna funding for bird flu vaccine after HHS review finds it doesn't meet safety and ...

Shares of Moderna Inc. fell over 2% on Wednesday after the U.S. Department of Health and Human Services (HHS) withdrew its ...

The revised version of the vaccine, marketed as Spikevax, follows FDA guidance recommending that this year’s shots target ...

Moderna (NASDAQ: MRNA) announced Wednesday that the Trump administration has canceled a major contract for the late-stage ...